Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Biotech
Viking sails oral weight loss drug to ph 2 after clinical win
Novo Nordisk may be racing to get an oral successor to its Wegovy weight loss sensation through clinical trials, but Viking is sailing up close behind.
James Waldron
Mar 26, 2024 10:04am
Viking's GLP-1 spurs steep weight loss, sending shares up 80%
Feb 27, 2024 10:15am
NodThera's NLRP3 inhibitor nearly matches Wegovy for weight loss
Feb 21, 2024 8:30am
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
Amgen's obesity drug may help patients keep the weight off
Feb 7, 2024 10:40am
Regeneron to fill gaps in obesity, break ground in cell therapy
Feb 2, 2024 10:25am